With over 12 years of experience spanning global regulatory affairs, drug development, and clinical research, Odette brings a wealth of expertise—particularly in advancing innovative therapies for rare and underserved diseases. Her career has been shaped by a deep commitment to ensuring that novel treatments are both effective and safe, especially for vulnerable populations including children.

Reetu Gupta is Chair of the Health Scientific Board at the Maroon Research Institute, where she leads initiatives at the intersection of women’s health, healthy longevity, and climate-driven determinants of health. She also serves as the Head of California & India Partnerships & Community for the Institute. Reetu is a seasoned strategic leader reflecting a 20+ year track record in healthcare, finance, and is passionate about how Climate has a direct impact on Health. Previously Vice President Customer Success at Brightline Health and 10+ year tenure at Kaiser Permanente, encompassing new program development, strategic partnerships and M&A.  She brings her healthcare and innovation experience advising purpose-driven founders.

She have successfully founded and scaled institutional firms and ventures; establishing a track record globally over 20+ years as a transformative leader, astute institutional investor; arranger (US$30bn+); and catalytic entrepreneur across private credit and growth equity (as both GP & Limited Partner)Managing Partner for Maroon Venture Fund I LP investing anchor capital to advance Health span & Longevity Science by closing material innovation & funding gaps in proactive, personalized Preventative Health for chronic Population Health conditions and direct Climate impact on Health. Coming from an innovative, very successful, multi-generational family business in Precision Medicine, Genetics & Preventative Health, I have an intrinsic respect & commitment to addressing single digit statistics undermining early detection, diagnosis & prevention of chronic Pop. Health conditions

Dr. Diana Martina Schaffer is an Austrian-based clinical and health psychologist with a PhD in Medical Science, an MA in Psychology, and a BA in Computer Science. She combines clinical expertise with strong technical skills and entrepreneurial experience, and is the founder of an AI-driven mental health startup focused on trauma-informed, image-based interventions inspired by EMDR and ImTT. Her work sits at the intersection of psychology, artificial intelligence, and digital health, with a focus on scalable, evidence-based support solutions for international markets.

Ms. Pelletier is an expert in women’s health, with insight driven by both intensive consumer research and deep commercial experience in the global markets with products addressing women’s health spanning every stage in their reproductive journey, from puberty to menopause. Her career in the pharmaceutical industry has spanned more than three decades, during which she has launched pharmaceutical brands worldwide and expanded indications for female healthcare brands in multiple countries. She is a published author, TEDx and keynote speaker, executive coach and staunch advocate for innovation in women’s healthcare. During her 10-year tenure as Chief Executive Officer, President and Executive Director of Evofem Biosciences, Inc. (OTCPK: EVFM), Ms. Pelletier has led the company through its transition to the public market, the approval of PHEXXI, the first and only hormone-free, on-demand prescription contraceptive vaginal gel, the acquisition of SOLOSEC, an FDA-approved single-dose oral antimicrobial agent for the treatment of two common sexual health infections: trichomoniasis and bacterial vaginosis, and four consecutive years of net sales growth.

Trevor Wilkins is a career-long founder, operator, investor, and coach in the early-stage ventures space. A former Forbes 30 Under 30 Nominee, Trevor relocated to Los Angeles as an investor for Quake Capital to help establish their local office. During the pandemic, he served as the VP of Partner Engagement at ScaleHealth, a health innovation marketplace, where he connected payer, provider, and pharma organizations with agile startups. Currently, Trevor leads monthly fireside chats on health tech market trends while helping healthcare startups navigate go-to-market strategies and business operations.

Naseeha Machingal is Senior Director of Client Success & Partnerships at Legal Ease Solutions, a leading Alternative Legal Service Provider specializing in legal consulting and solutions. She leads a global team across the US and India, managing strategic partnerships and driving revenue growth for the company's largest client portfolio. With over 7 years of experience building client success programs, scaling service delivery models, and navigating complex enterprise partnerships, Naseeha brings a practitioner's perspective on what it takes to grow a services business by putting clients at the center. She is also an avid mountaineer who has summited Kilimanjaro, Mount Whitney, and Pikes Peak.

Matthew Rota is the Vice President of Operations at Repeat Therapeutics, where he leads company programs with a focus on execution, early-stage development, and cross-functional strategy. His background spans drug development, technology transfer, and commercial operations, with prior roles at Catalent Pharma Solutions and TriLink BioTechnologies. He brings a practical startup perspective on how emerging health companies can move from promising science to scalable impact.

Kimberly Chew is senior counsel in Husch Blackwell LLP’s virtual office, The Link, where she co-leads the firm’s psychedelic and emerging therapies practice. With a robust background in biotech research, Kimberly guides life sciences clients through the intricate landscape of clinical trials, FDA regulations, and academic research compliance. Her practice encompasses regulatory due diligence and intellectual property enforcement, particularly in patent infringement and validity. She helps drug developers and entrepreneurs navigate the complexities of the life sciences sector, addressing regulatory and commercial challenges to achieve business goals.